Enovis CORP financial data

Symbol
ENOV on NYSE
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Location
2711 Centerville Road, Suite 400, Wilmington, DE
State of incorporation
DE
Fiscal year end
December 31
Former names
Colfax CORP (to 3/18/2022)
Latest financial report
10-K - Q4 2024 - Feb 26, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 220 % -9.59%
Quick Ratio 111 % -13.6%
Debt-to-equity 69.6 % +146%
Return On Equity -26.4 % -2632%
Return On Assets -15.6 % -1968%
Operating Margin -36.8 % -856%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 57M shares +3.85%
Common Stock, Shares, Outstanding 55.9M shares +2.34%
Entity Public Float 2.46B USD -29.3%
Common Stock, Value, Issued 56K USD +1.82%
Weighted Average Number of Shares Outstanding, Basic 55.3M shares +1.44%
Weighted Average Number of Shares Outstanding, Diluted 55.3M shares +1.44%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.11B USD +23.5%
Research and Development Expense 91.3M USD +21.2%
Operating Income (Loss) -776M USD -1081%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -823M USD -1126%
Income Tax Expense (Benefit) 4.49M USD +552%
Net Income (Loss) Attributable to Parent -825M USD -2382%
Earnings Per Share, Basic -14.9 USD/shares -2348%
Earnings Per Share, Diluted -14.9 USD/shares -2348%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 48.2M USD +33.1%
Accounts Receivable, after Allowance for Credit Loss, Current 407M USD +39.6%
Inventory, Net 547M USD +16.7%
Other Assets, Current 108M USD +51.7%
Assets, Current 1.15B USD +27.9%
Property, Plant and Equipment, Net 405M USD +49.4%
Operating Lease, Right-of-Use Asset 68.9M USD +8.52%
Intangible Assets, Net (Excluding Goodwill) 1.32B USD +16.9%
Goodwill 1.69B USD -17.9%
Other Assets, Noncurrent 88.8M USD -1.64%
Assets 4.72B USD +4.65%
Accounts Payable, Current 179M USD +35.2%
Employee-related Liabilities, Current 86M USD +21.1%
Accrued Liabilities, Current 330M USD +39.1%
Liabilities, Current 529M USD +43.1%
Other Liabilities, Noncurrent 264M USD +29.1%
Liabilities 2.15B USD +97.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -128M USD -414%
Retained Earnings (Accumulated Deficit) -283M USD -152%
Stockholders' Equity Attributable to Parent 2.56B USD -25%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 2.56B USD -25%
Liabilities and Equity 4.72B USD +4.65%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -36.2M USD -585%
Net Cash Provided by (Used in) Financing Activities 865M USD +3429%
Net Cash Provided by (Used in) Investing Activities -798M USD -2220%
Common Stock, Shares Authorized 133M shares 0%
Common Stock, Shares, Issued 55.9M shares +2.34%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 29.7M USD
Deferred Tax Assets, Valuation Allowance 156M USD +53.9%
Operating Lease, Liability 74.8M USD +13%
Payments to Acquire Property, Plant, and Equipment 36.9M USD +21.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -928M USD -19593%
Lessee, Operating Lease, Liability, to be Paid 80.6M USD +12.4%
Property, Plant and Equipment, Gross 724M USD +41.1%
Operating Lease, Liability, Current 34.6M USD +21.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 18.3M USD +11.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 21.1M USD +7.89%
Deferred Income Tax Expense (Benefit) -9.97M USD -1299%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.84M USD +6.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 10.9M USD -4.58%
Deferred Tax Assets, Operating Loss Carryforwards 39.3M USD +5.2%
Unrecognized Tax Benefits 31.4M USD -2.15%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.8M USD +21.8%
Additional Paid in Capital 2.97B USD +2.5%
Amortization of Intangible Assets 166M USD +24%
Depreciation, Depletion and Amortization 6.43M USD -15.4%
Deferred Tax Assets, Net of Valuation Allowance 233M USD +2.28%
Share-based Payment Arrangement, Expense 29.7M USD -7.46%
Interest Expense 57.1M USD +189%